NCT00157534
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
- Locations
-
Not specified
Clinical trial condition
Flaviviridae Infections
Explore clinical trials studying Flaviviridae Infections. Study availability and eligibility vary by location and protocol.
2,143 public trials
76 recruiting studies
Flaviviridae Infections trial results
NCT00146016
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
- Locations
-
- UMC Utrecht Utrecht, Netherlands
Completed
Phase III Randomized Study of High Vs Standard Dose of Interferon Alfa for Chronic Hepatitis C
NCT00004804
- Conditions
- Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +13 more
- Locations
-
Not specified
Active, Not Recruiting
Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk
NCT05657106
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Chemically-Induced Disorders, +36 more
- Locations
-
- University of Kentucky Lexington, Kentucky, United States
Active, Not Recruiting
DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection
NCT02772003
- Conditions
- Adenocarcinoma, Blood-Borne Infections, Carcinoma, +25 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
- Case Western Reserve University Cleveland, Ohio, United States
- Temple University Hospital Philadelphia, Pennsylvania, United States
Active, Not Recruiting
A Study on a New Tetravalent Dengue Vaccine (TDV) Formulation in Healthy Adults
NCT07047521
- Conditions
- Arbovirus Infections, Dengue, Dengue Fever, +8 more
- Locations
-
- Paratus Clinical Research Western Sydney Blacktown, New South Wales, Australia
- Emeritus Research Sydney Botany, New South Wales, Australia
- Paratus Clinical Research Central Coast Kanwal, New South Wales, Australia
- Veritus Research Bayswater, Victoria, Australia
Active, Not Recruiting
The HOPE Study: Characterizing Patients With Hepatitis B and C
NCT02995252
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +18 more
- Locations
-
- Institute of Human Virology, University of Maryland School of Medicine Baltimore, Maryland, United States
- Dr Huong Dang, Medical Practice Falls Church, Virginia, United States
Active, Not Recruiting
People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
NCT03520660
- Conditions
- Adenocarcinoma, Blood-Borne Infections, Carcinoma, +30 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Active, Not Recruiting
C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV
NCT07037277
- Conditions
- Blood-Borne Infections, Chronic Disease, Communicable Diseases, +16 more
- Locations
-
- Atea Study Site Cairo, Egypt
- Atea Study Site Nice, Alpes Maritimes, France
- Atea Study Site Strasbourg, Bas Rhin, France
- Atea Study Site Clichy, Hauts De Seine, France
Active, Not Recruiting
DBS TaT in Peer-assisted Telemedicine for Hepatitis C
NCT06409169
- Conditions
- Blood-Borne Infections, Chemically-Induced Disorders, Communicable Diseases, +11 more
- Locations
-
- Oregon Health & Science University Portland, Oregon, United States